View Older Stories View More Recent Stories

Oct 30, 2017 08:00AM Ironwood Highlights Breadth of Gout Research to be Presented at the 2017 ACR/ARHP Annual Meeting
Oct 19, 2017 04:01PM Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call
Oct 16, 2017 08:00AM Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017
Sep 6, 2017 08:00AM Ironwood Pharmaceuticals Announces Leadership Change
Aug 31, 2017 04:01PM Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Aug 21, 2017 08:02AM Ironwood Pharma (IRWD) Announces FDA Approval of DUZALLO for Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Aug 21, 2017 08:00AM Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Aug 3, 2017 04:01PM Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update
Jul 20, 2017 04:01PM Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call
Jul 20, 2017 08:02AM Ironwood Pharma (IRWD) says IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease Met Primary Endpoint
Jul 20, 2017 08:00AM Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease
Jun 8, 2017 04:01PM Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Jun 1, 2017 04:01PM Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 10, 2017 04:01PM Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
May 9, 2017 04:56PM Ironwood Pharma (IRWD) Presents Data Further Elucidating Linaclotide's Effect on Pain at DDW
May 9, 2017 04:05PM Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide’s Effect on Pain at Digestive Disease Week® 2017
May 8, 2017 08:00AM Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
May 1, 2017 07:30AM Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017
Apr 24, 2017 04:01PM Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
Apr 13, 2017 09:00AM Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
Apr 6, 2017 08:00AM Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer
Mar 10, 2017 04:01PM Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 9, 2017 08:30AM Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
Feb 28, 2017 04:01PM Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference
Feb 23, 2017 04:01PM Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017
Feb 21, 2017 04:01PM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
Feb 7, 2017 04:01PM Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call
Jan 29, 2017 07:00PM Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial for Patients with Chronic Constipation Conducted in Japan
Jan 26, 2017 07:13AM Ironwood Pharmaceuticals (IRWD), Allergan (AGN) Gains FDA Approval for 72 mcg Dose of LINZESS
Jan 26, 2017 07:01AM U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation
Jan 9, 2017 05:55AM Ironwood Pharma (IRWD) to Detail Strong Execution Strategy at JPMorgan Conference
Jan 8, 2017 08:00PM Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech
Jan 4, 2017 04:05PM Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors
Jan 4, 2017 08:04AM Ironwood Pharma (IRWD) Says FDA Accepts DUZALLO NDA
Jan 4, 2017 08:00AM Ironwood Announces New Drug Application for DUZALLO™ (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review
Jan 3, 2017 04:01PM Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dec 22, 2016 07:03AM Ironwood (IRWD), Allergan (AGN) Announce Phase IIb Data for Linaclotide Colonic Release-1 (CR1) in IBS-C; Plan to Advance to Phase III
Dec 22, 2016 07:00AM Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C
Dec 22, 2016 07:00AM Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS
Dec 19, 2016 06:01AM Ironwood Pharma (IRWD) LINZESS Approved in Japan for Adults with IBS-C
Dec 19, 2016 06:00AM Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in Japan for the Treatment of Adults with IBS-C
Nov 14, 2016 07:09AM Ironwood Pharma (IRWD) Announces Presentation of Additional Data from ZURAMPIC Phase 3s
Nov 13, 2016 08:00AM Ironwood Highlights ZURAMPIC® (lesinurad) Phase III Extension Study Data at the American College of Rheumatology 2016 Annual Meeting
Nov 10, 2016 04:01PM Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
Nov 3, 2016 08:01AM Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update
Nov 1, 2016 04:01PM Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference
Oct 25, 2016 08:00AM Ironwood Highlights Breadth of Gout Research with Presentations at the American College of Rheumatology 2016 Annual Meeting
Oct 20, 2016 04:01PM Ironwood Pharmaceuticals to Host Third Quarter 2016 Investor Update Call
Oct 3, 2016 08:00AM Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows
Oct 3, 2016 07:30AM Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout
View More Recent Stories View Older Stories